RT Journal Article
SR Electronic
T1 Prophylactic Magnesium Supplementation and New-Onset Atrial Fibrillation in a General Critical Care Population: A Prescribing Preference Instrumental Variable Analysis
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2021.11.25.21266861
DO 10.1101/2021.11.25.21266861
A1 Wilson, Matthew G.
A1 Rashan, Aasiyah
A1 Klapaukh, Roman
A1 Asselbergs, Folkert W.
A1 Harris, Stephen K.
YR 2021
UL http://medrxiv.org/content/early/2021/11/26/2021.11.25.21266861.abstract
AB Aims Atrial fibrillation is frequently encountered in critical illness and causes adverse effects including haemodynamic decompensation, stroke and longer hospital stay. It is common to supplement serum magnesium for the purpose of preventing new-onset atrial fibrillation. However, no randomised studies support this practice in the non-cardiac surgery critical care population, and its effectiveness is unclear. We sought to investigate the effectiveness of magnesium supplementation in preventing new-onset atrial fibrillation in a mixed critical care population.Methods We conducted a single centre retrospective observational study of adult critical care patients. We employed a natural experiment design, using the supplementation preference of the bedside critical care nurse as an instrumental variable.Using the electronic patient record, magnesium supplementation opportunities were defined and linked to the bedside nurse. Nurse preference for administering magnesium was obtained using multilevel modelling. The results were used to define ‘pro’ and ‘anti’ supplementation groups, which were inputted into an instrumental variable regression to obtain an estimate of the effect of magnesium supplementation.Results 9,114 magnesium supplementation opportunities were analysed, representing 2,137 critical care admissions for 1,914 patients. There was significant variation in magnesium supplementation practices attributable to the individual nurse, after accounting for covariates. The instrumental variable analysis showed magnesium supplementation was associated with a 3% decreased chance of experiencing new-onset atrial fibrillation (95% CI −0.06 to −0.04, p = 0.03).Conclusions This study supports the strategy of routine magnesium supplementation, but further work is required to identify optimal serum magnesium targets for prophylaxis of atrial fibrillation.What’s New?Routine administration of supplemental magnesium sulphate is associated with a reduced chance of developing new-onset Atrial Fibrillation, in a general critical care cohort.This finding agrees with previous Randomised Controlled Trial results which are limited to the cardiac critical care population.This finding disagrees with previously published observational studies, which is likely due to better control of unmeasured confounding.There is significant variation in serum magnesium supplementation attributable to the individual bedside critical care nurse.Electronic health records offer the ability to evaluate the effectiveness of routinely administered treatments which lack evidence in an affordable way.Natural experiments and instrumental variable analysis offer the opportunity to derive causally robust estimations of treatment effectiveness by better accounting for unobserved confounding.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis study did not receive specific funding. The authors received supporting funding as follows: MGW is supported by doctoral training program funding via the Medical Research Council. FWA and SKH are supported by University College London Hospitals National Institute for Health Research Biomedical Research Centre. SKH is supported by a Health Foundation Improvement Science Fellowship.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:This study used routinely collected Electronic Health Record (EHR) data from critical care admissions to a tertiary referral centre in the United Kingdom. Patient data was collected under the auspices of the Critical Care Health Informatics Collaborative (CCHIC). CCHIC has an exemption to collect identifiable clinical data under an opt-out consent framework, for the purposes of conducting secondary research. This is facilitated through an exemption to standard confidentiality law, detailed under Section 251 of the National Health Service (NHS) Act, 2006 (14/CAG/1001) and approved by the National Research Ethics Service (14/LO/103). An application for data access pertinent to the study question was approved by the CCHIC Scientific Advisory Group. Data was stored and analysed in the University College London Data Safe Haven, a secure data environment conforming to NHS Digital's Information Governance Toolkit.I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAnalysis code used in the study is available upon reasonable request to the authors. Enquiries regarding accessing identifiable patient level data may be directed to the UCL Critical Care Health Informatics Collaborative via the corresponding author.